Richard Hudes, MD
Radiation Oncology · Baltimore, MDNPI 1891796926
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,052 and has fallen 67.2% since, to $345 in 2025.
Across 78 payments — averaging $43.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$583
- Progenics Pharmaceuticals, Inc.$405
- Teleflex LLC$357
- Sumitomo Pharma America, Inc.$310
- Bioprotect Medical, Inc.$241
- Palette Life Sciences, Inc.$208
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$1123%
- Food & beverage$3,25197%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $583 |
| Progenics Pharmaceuticals, Inc. | 6 | $405 |
| Teleflex LLC | 4 | $357 |
| Sumitomo Pharma America, Inc. | 9 | $310 |
| Bioprotect Medical, Inc. | 10 | $241 |
| Palette Life Sciences, Inc. | 4 | $208 |
| Bayer | 6 | $163 |
| Novocure Inc. | 1 | $143 |
| Immunitybio, Inc. | 1 | $135 |
| Myriad Genetic Laboratories, Inc. | 7 | $130 |
| Medtronic | 1 | $95 |
| AbbVie | 2 | $90 |
| Endo Pharmaceuticals Inc. | 1 | $81 |
| Urogen Pharma, Inc. | 1 | $76 |
| Myovant Sciences Inc. | 3 | $69 |
| Novartis | 2 | $48 |
| Blue Earth Diagnostics | 2 | $46 |
| Merck | 1 | $32 |
| MIM Software Inc. | 1 | $32 |
| Bard Peripheral Vascular, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| Tolmar, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Accuray Incorporated | 1 | $15 |
| Elekta, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,362 in reported general payments places this provider in the 80th percentile of 108 radiation oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 58 | $1,151 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Baltimore
- Sahaja AcharyaBaltimore$200K
- Arpit ChhabraBaltimore$97K
- Lawrence KleinbergBaltimore$34K
- Danny SongBaltimore$32K
- Jason MolitorisBaltimore$26K
- Kristin RedmondBaltimore$17K
- Avani RaoBaltimore$10K
- Amanda WalkerBaltimore$9K
- Christopher JohnsonBaltimore$7K
- Russell HalesBaltimore$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.